# Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer

> **NCT05183126** · PHASE4 · RECRUITING · sponsor: **University of Michigan Rogel Cancer Center** · enrollment: 22 (estimated)

## Conditions studied

- Breast Cancer
- Metastatic Gastric Cancer
- Esophageal Cancer

## Interventions

- **DRUG:** Paclitaxel
- **DRUG:** Paclitaxel

## Key facts

- **NCT ID:** NCT05183126
- **Lead sponsor:** University of Michigan Rogel Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-03-28
- **Primary completion:** 2026-06
- **Final completion:** 2026-06
- **Target enrollment:** 22 (ESTIMATED)
- **Last updated:** 2026-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05183126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05183126, "Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05183126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*